HIGFBMAG-53K

MILLIPLEX^® Human IGF Binding Protein Magnetic Bead Panel - Metabolism Multiplex Assay

The Human IGF Binding Protein Panel, using the Luminex xMAP technology, enables the simultaneous analysis of 7 IGFBP protein biomarkers in human serum, plasma and cell culture samples.

• UNSPSCコード: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

特性

• 品質水準: 200
• 化学種の反応性: human
• メーカー／製品名: Milliplex^®
• assay range: accuracy: 79%; (IGFBP-5); sensitivity: 0.01 ng/mL; (MinDC+2SD; IGFBP-1); sensitivity: 0.07 ng/mL; (MinDC+2SD; IGFBP-7); sensitivity: 0.12 ng/mL; (MinDC+2SD; IGFBP-6); sensitivity: 0.15 ng/mL; (MinDC+2SD; IGFBP-3); sensitivity: 0.96 ng/mL; (MinDC+2SD; IGFBP-4); sensitivity: 1.09 ng/mL; (MinDC+2SD; IGFBP-2); sensitivity: 9.87 ng/mL; (MinDC+2SD; IGFBP-5); standard curve range: 0.03-25 ng/mL; (IGFBP-1); standard curve range: 0.07-50 ng/mL; ( IGFBP-3); standard curve range: 0.07-50 ng/mL; (IGFBP-7); standard curve range: 0.14-100 ng/mL; (IGFBP-6); standard curve range: 0.34-250 ng/mL; (IGFBP-2); standard curve range: 0.69-500 ng/mL; (IGFBP-4); standard curve range: 1.37-1000 ng/mL; (IGFBP-5); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-1); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-2); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-3); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-4); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-5); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-6); inter-assay cv: <15%; intra-assay cv: <10%; (IGFBP-7)
• テクニック: multiplexing: suitable
• 検出方法: fluorometric (Luminex xMAP)
• 輸送温度: wet ice

詳細

詳細

Insulin-like growth factor (IGF) binding proteins (IGFBP) are expressed by multiple tissues and cells, including hepatic cells. By binding both IGF-1 and IGF-2, IGFBPs play a critical role in the regulation of IGF action, altering IGF interaction with cell surface receptors and increasing circulating IGF half-life and bioavailability. While their functions at the cellular level are not fully understood, studies have demonstrated the capacity to both stimulate and inhibit IGF-1 activity, depending on the system involved and the IGFBP studied. The ability of IGFBPs to regulate cell sensitivity by inhibiting IGF signaling may function in the control of tumor cell growth.

The MILLIPLEX^® Human IGF Binding Protein (IGFBP) Panel, is used for the simultaneous quantification of any or all of the following analytes in human serum, plasma, and cell culture conditioned-media samples: IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6, and IGFBP-7. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex^® xMAP^® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Endocrine

特異性

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes in this panel.

アプリケーション

• Analytes: IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, IGFBP-6, IGFBP-7
• Recommended Sample Type: Human serum, plasma, and cell culture conditioned-media
• Recommended Sample Dilution: For serum and plasma samples, 25 μL per well of a 1:25 dilution should be used when IGFBP3 is not included in the assay. Use a 1:200 dilution when IGFBP3 is included in the assay. Tissue culture supernatants may be run undiluted or appropriately diluted with control medium.
• Assay Run Time: Overnight (16-20 hours) at 2-8°C. For improved sensitivity for some analytes use a 2 hour incubation at room temperature (20-25°C).
• Research Category: Metabolism
• Research Subcategory: Metabolic Disorders

特徴および利点

Design your multiplex kit by choosing available analytes within this panel.

包装

Everything you need in a single kit.

96 well plate

保管および安定性

Recommended storage for kit components is 2 - 8°C.

その他情報

Please contact Technical Service for linearity of dilution.

法的情報

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全性情報

• ピクトグラム: GHS06,GHS09
• シグナルワード: Danger
• 危険有害性情報: H302 + H332,H311,H317,H319,H411
• 注意書き: P273 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects